R&D is driven forward by Creavis, our strategic innovation unit. Working closely with the segments, Creavis is engaged in research into new technologies.
It concentrates on mid- and long-term projects, which are driven forward in a variety of ways. Its principal areas of focus are Evonik’s strategic growth fields, and its work is linked to the segments’ R&D activities. Examples are development of new gas separation membranes, which add new technologies to our SEPURAN® platform.
On the basis of identified potential in the strategic growth fields, Creavis sets up project houses. These spend three years exploring an area of innovation in conjunction with the segments and external experts. For example, the Medical Devices Project House in the Healthcare Solutions growth field is currently working on new solutions for medical technology and extending Evonik’s competence in biomaterials and polymers. In particular, it is addressing applications in implantology. The Composites Project House ended in spring 2016. Notable successes were materials and processes that enable automated production of composites at competitive prices. When the scheduled period for this project house ended, the new materials and system solutions were integrated into the Resource Efficiency and Performance Materials segments.
As a general rule, we connect the chemical expertise available in the Evonik Group with our competence in process technology and engineering at an early stage in projects. This facilitates rapid transfer of new processes to efficient industrial production.
Evonik Creavis GmbH
With the strategic innovation unit to new Business.more